阿达木单抗治疗红皮病型银屑病3例

doi:10.35541/cjd.20210001

Chinese Journal of Dermatology ›› 2023, Vol. 56 ›› Issue (5): 444-446.doi: 10.35541/cjd.20210001

• Case Reports • Previous Articles Next Articles

Adalimumab for the treatment of three cases of erythrodermic psoriasis

Yin Hanjing, Xi Chan, Wang Huiping, Luo Suju

Department of Dermatology and Venereology, Tianjin Medical University General Hospital, Tianjin 300052, China

Received:2021-01-04 Revised:2022-01-02 Online:2023-05-15 Published:2023-05-04
Contact: Luo Suju E-mail:luosuju2005@163.com
Supported by:
National Natural Science Foundation of China（81773319）

Abstract

Yin Hanjing, Xi Chan, Wang Huiping, Luo Suju. Adalimumab for the treatment of three cases of erythrodermic psoriasis[J]. Chinese Journal of Dermatology, 2023, 56(5): 444-446.doi:10.35541/cjd.20210001

References ［5］

［1］	刘洛辰, 刘小菡, 张红婧, 等. 司库奇尤单抗治疗红皮病型银屑病2例［J］. 中国皮肤性病学杂志, 2021,35（1）:116⁃117. doi: 10.13735/j.cjdv.1001⁃7089.202005115.
［2］	张瑞丽, 朱小红, 华海康, 等. 阿达木单抗治疗重度银屑病14例临床疗效及安全性观察［J］. 中华皮肤科杂志, 2018,51（8）:604⁃606. doi: 10.3760/cma.j.issn.0412⁃4030.2018.08.012.
［3］	Carrasquillo OY, Pabón⁃Cartagena G, Falto⁃Aizpurua LA, et al. Treatment of erythrodermic psoriasis with biologics: a systematic review［J］. J Am Acad Dermatol, 2020,83（1）:151⁃158. doi: 10. 1016/j.jaad.2020.03.073.
［4］	中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会, 中国中西医结合学会皮肤性病专业委员会. 中国银屑病生物制剂治疗指南（2021）［J］. 中华皮肤科杂志, 2021,54（12）:1033⁃1047. doi: 10.35541/cjd.20210643.
［5］	Durmazlar SP, Oktay B, Eren C, et al. Cushing′s syndrome caused by short⁃term topical glucocorticoid use for erythrodermic psoriasis and development of adrenal insufficiency after glucocorticoid withdrawal［J］. Eur J Dermatol, 2009,19（2）:169⁃170. doi: 10.1684/ejd.2008.0584.

Adalimumab for the treatment of three cases of erythrodermic psoriasis

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［5］

Related Articles 0

Metrics

Comments

Recommended 10